Skip to main content

Profile hero

Dr. Sabrina Kulenkamp

Partner

Corporate advisory and governance | ESG and sustainability | Life sciences | Mergers and acquisitions |

very strong, the best of the new generation

Competitor, JUVE 2022/23

Profile details

About Dr. Sabrina Kulenkamp

Sabrina advises listed and non-listed clients in stock corporation law and capital markets law, including Corporate Governance, and monitors regularly national and cross-border private and public M&A transactions.

She speaks German, English, Spanish and Armenian.

Recent work

  • Novartis on the public takeover of MorphoSys, the delisting purchase offer and the merger squeeze-out
  • BASF on the merger between Wintershall Dea and Harbour Energy
  • BorgWarner on the public takeover of Akasol
  • TE Connectivity on the public takeover of First Sensor and on the conclusion of a domination and profit and loss pooling agreement with Akasol
  • OSRAM Licht on the competing public takeover offers by Bain Capital/Carlyle and ams, the domination and profit and loss pooling agreement with ams and the delisting
  • STADA Arzneimittel in the context of the auction process and subsequent public takeover by Bain Capital and Cinven as well as the conclusion of a domination and profit and loss pooling agreement with Bain Capital and Cinven 
  • London Stock Exchange on the proposed business combination with Deutsche Börse

Qualifications

Education

  • Universities of Heidelberg, Germany, and Salamanca, Spain (law)
  • University of Mannheim, Germany (Dr iur)
  • 2010 admitted to the German Bar

Publications

  • Seibt/Buck-Heeb/Harnos, BeckOK Wertpapierhandelsrecht Co-author of the commentary on the European Market Abuse Regulation

  • AG 2018, 549 (jointly with Christoph H. Seibt) Handlungsoptionen der Geschäftsleitung einer Zielgesellschaft nach Kontrollerwerb und vor Wirksamwerden eines Beherrschungsvertrags

  • Hirte/Seibt, Kölner Kommentar WpÜG Co-author of the leading commentary on the German Takeover Act

  • ZIP 2017, 1345 (jointly with Christoph H. Seibt) CFIUS-Verfahren und Folgen für M&A-Transaktionen mit Beteiligung deutscher Unternehmen – und als Modell für die Weiterentwicklung des deutschen Außenwirtschaftsrechts?

  • Krieger/Schneider (editors), Handbuch Managerhaftung (4th ed 2023) Managerhaftung bei M&A Transaktionen

  • Bauer/Schuster (editors), Nachhaltigkeit im Bankensektor (2016) (jointly with Klaus Lackhoff) Sicherung der Funktionserbringung von nicht regulierten Aktiengesellschaften und Kreditinstituten durch Corporate Governance

  • DB 2020, 775 (with Thomas Bücker et al.) Praxisleitfaden zur virtuellen Hauptversammlung (COVID-19-Pandemie-AuswBekG)

  • Bachmann/Casper/Schäfer/Veil (editors), Schriften zum Gesellschafts-, Bank- und Kapitalmarktrecht (Nomos 2009) Die grenzüberschreitende Verschmelzung von Kapitalgesellschaften in der EU (Diss.)